Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems

Chemico-Biological Interactions

Volumn 109, Issue 1-3, 1998, Pages 195-219

  Glatt, Hansruedi ^a,b   Bartsch, Ingrid ^b   Christoph, Stefanie ^b   Coughtrie, Michael W H ^f   Falany, Charles N ^c   Hagen, Maria ^a   Landsiedel, Robert ^a   Pabel, Ulrike ^a   Phillips, David H ^d   Seidel, Albrecht ^b   Yamazoe, Yasushi ^e  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c University of Alabama at Birmingham   (United States)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e TOHOKU UNIVERSITY   (Japan)

^f NONE

Author keywords

Aromatic amines; Benzylic alcohols; Chinese hamster V79 cells; Hycanthone; Mutagenicity; Polycyclic aromatic hydrocarbons; Safrole; Salmonella typhimurium; Sulfotransferase; Tamoxifen

Indexed keywords

1' HYDROXYSAFROLE; BENZYL ALCOHOL DERIVATIVE; DNA; HYCANTHONE; HYDROXYTAMOXIFEN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MUTAGENIC AGENT; N (2 FLUORENYL)ACETAMIDE; POLYCYCLIC AROMATIC HYDROCARBON; SAFROLE; SULFATE; SULFOTRANSFERASE; TIOGUANINE; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL LINE; CHINESE HAMSTER; CONFERENCE PAPER; CYTOTOXICITY; GENE EXPRESSION SYSTEM; GENE MUTATION; HUMAN; MUTAGEN TESTING; NONHUMAN; RAT; SALMONELLA TYPHIMURIUM; SISTER CHROMATID EXCHANGE;

ANIMALS; BENZO(A)PYRENE; BIOTRANSFORMATION; CARCINOGENS; CRICETINAE; CRICETULUS; ENZYME ACTIVATION; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MUTAGENICITY TESTS; MUTAGENS; PYRENES; RATS; SALMONELLA TYPHIMURIUM; SISTER CHROMATID EXCHANGE; SULFOTRANSFERASES;

EID: 0032549062     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00133-6     Document Type: Conference Paper

References (57)

1. Hollstein M., McCann J., Angelosanto F.A., Nichols W.W. Short-term tests for carcinogens and mutagens. Mutat. Res. 65:1979;133-226.
2. Glatt H.R., Pauly K., Piée-Staffa A., Seidel A., Hornhardt S., Czich A. Activation of promutagens by endogenous and heterologous sulfotransferases expressed in continuous cell cultures. Toxicol. Lett. 72:1994;13-21.
3. Watabe T., Ishizuka T., Isobe M., Ozawa N. A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[a]anthracene. Science. 215:1982;403-405.
4. Glatt H.R., Henschler R., Phillips D.H., Blake J.W., Steinberg P., Seidel A., Oesch F. Sulfotransferase-mediated chlorination of 1-hydroxymethylpyrene to a mutagen capable of penetrating indicator cells. Environ. Health Perspect. 88:1990;43-48.
5. Enders N., Seidel A., Monnerjahn S., Glatt H.R. Synthesis of 11 benzylic sulfate esters, their bacterial mutagenicity and its modulation by chloride, bromide and acetate anions. Polycyclic Aromat. Compds. 3(Suppl.):1993;887-894.
6. Landsiedel R., Engst W., Seidel A., Glatt H.R. Physico-chemical properties and mutagenicity of benzylic compounds. Exp. Toxicol. Pathol. 48(Suppl. II):1996;215-222.
7. Landsiedel R., Engst W., Scholtyssek M., Seidel A., Glatt H.R. Benzylic sulphuric acid esters react with diverse functional groups and often form secondary reactive species. Polycyclic Aromat. Compds. 11:1996;341-348.
8. Falany C.N., Wheeler J., Oh T.S., Falany J.L. Steroid sulfation by expressed human cytosolic sulfotransferases. J. Steroid. Biochem. Mol. Biol. 48:1994;369-375.
9. Glatt H.R., Pauly K., Czich A., Falany J.L., Falany C.N. Activation of benzylic alcohols to mutagens by rat and human sulfotransferases expressed in Escherichia coli. Eur. J. Pharmacol. 293:1995;123-131.
10. Ganguly T.C., Krasnykh V., Falany C.N. Bacterial expression and kinetic characterization of the human monoamine-sulfating form of phenol sulfotransferase. Drug Metab. Dispos. 23:1995;945-950.
11. Hagen M., Pabel U., Bartsch I., Landsiedel R., Falany C.N., Glatt H.R. Heterologous expression of human estrogen sulfotransferase in Salmonella typhimurium and its use for mutagenicity studies. Chem. Biol. Interact. 109:1998;249-253. (this issue).
12. + for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156:1983;471-474.
13. Artelt P., Morelle C., Ausmeier M., Fitzek M., Hauser H. Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection. Gene. 68:1988;213-219.
14. Czich A., Bartsch I., Dogra S., Hornhardt S., Glatt H.R. Stable heterologous expression of hydroxysteroid sulfotransferase in Chinese hamster V79 cells and their use for toxicological investigations. Chem.-Biol. Interact. 92:1994;119-128.
15. Watabe T., Ogura K., Satsukawa M., Okuda H., Hiratsuka A. Molecular cloning and functions of rat liver hydroxysteroid sulfotransferases catalysing covalent binding of carcinogenic polycyclic arylmethanols to DNA. Chem.-Biol. Interact. 92:1994;87-105.
16. Nagata K., Ozawa S., Miyata M., Shimada M., Gong D.W., Yamazoe Y., Kato R. Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. J. Biol. Chem. 268:1993;24720-24725.
17. Wölfel C., Platt K.-L., Dogra S., Glatt H.R., Wächter F., Doehmer J. Stable expression of rat cytochrome P450IA2 cDNA and hydroxylation of 17β-estradiol and 2-aminofluorene in V79 Chinese hamster cells. Mol. Carcinog. 4:1991;489-498.
18. Jones A.L., Hagen M., Coughtrie M.W.H., Roberts R.C., Glatt H.R. Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form. Biochem. Biophys. Res. Commun. 208:1995;855-862.
19. Forbes K.J., Hagen M., Glatt H.R., Hume R., Coughtrie M.W.H. Human fetal adrenal hydroxysteroid sulphotransferase: cDNA cloning, stable expression in V79 cells and functional characterization of the expressed enzyme. Mol. Cell. Endocrinol. 112:1995;53-60.
20. Glatt H.R. Comparison of common gene mutation tests in mammalian cells in culture: a position paper of the GUM Commission for the development of guidelines for genotoxicity testing. Mutat. Res. 313:1994;7-20.
21. Glatt H.R., Gemperlein I., Turchi G., Heinritz H., Doehmer J., Oesch F. Search for cell culture systems with diverse xenobiotic-metabolising activities and their use in toxicological studies. Mol. Toxicol. 1:1987;313-333.
22. Glatt H.R., Pauly K., Wölfel C., Dogra S., Seidel A., Lee H., Harvey R.G., Oesch F., Doehmer J. Stable expression of heterologous cytochromes P450 in V79 cells: mutagenicity studies with polycyclic aromatic hydrocarbons. Polycyclic Aromat. Compds. 3(Suppl. ):1993;1167-1174.
23. Krämer A., Pudil J., Frank H., Setiabudi F., Oesch F., Glatt H.R. Some substrates and inhibitors of cytosolic epoxide hydrolase induce sister-chromatid exchanges in mammalian cells, but do not induce gene mutations in Salmonella typhimurium and V79 cells. Mutat. Res. 290:1993;165-174.
24. Engst W., Landsiedel R., Hermersdörfer H., Doehmer J., Glatt H.R. Benzylic hydroxylation of 1-methylpyrene by cytochrome P450 species expressed in V79 cells. Exp. Toxicol. Pathol. 48(Suppl. II):1996;102-108.
25. Glatt H.R., Werle-Schneider G., Enders N., Monnerjahn S., Pudil J., Czich A., Seidel A., Schwarz M. 1-Hydroxymethylpyrene and its sulfuric acid ester: toxicological effects in vitro and in vivo and metabolic aspects. Chem.-Biol. Interact. 92:1994;305-319.
26. Glatt H.R. Mutagenicity spectra in Salmonella typhimurium strains of glutathione, L-cysteine and active oxygen species. Mutagenesis. 4:1989;221-227.
27. 1 mice. Biochem. Biophys. Res. Commun. 172:1990;85-91.
28. Surh Y.-J., Liem A., Miller E.C., Miller J.A. Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro. Carcinogenesis. 10:1989;1519-1528.
29. Miller E.C., Miller J.A., Boberg E.W., Delclos K.B., Lai C.-C., Fennell T.R., Wiseman R.W., Liem A. Sulfuric acid esters as ultimate electrophilic and carcinogenic metabolites of some alkenylbenzenes and aromatic amines in mouse liver. Huberman E., Barr S.H. Carcinogenesis. 1985;93-107 Raven Press, New York.
30. Hartman P.E. Early years of the Salmonella mutagen tester strains: lessons from hycanthone. Environ. Mol. Mutagen. 16:1989;39-45.
31. Williams G.M., Iatropoulos M.J., Djordevic M.V., Kaltenberg O.P. The triphenylene drug tamoxifen is a strong carcinogen in the rat. Carcinogenesis. 14:1993;315-317.
32. Phillips D.H., Potter G.A., Horton M.N., Hewer A., Croftonsleigh C., Jarman M., Venitt S. Reduced genotoxicity of [D-5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen. Carcinogenesis. 15:1994;1487-1492.
33. 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. Carcinogenesis. 15:1994;2087-2094.
34. Myers S.R., Blake J.W., Flesher J.M. Bioalkylation and bio-oxidation of anthracene, in vitro and in vivo. Biochem. Biophys. Res. Commun. 151:1988;1441-1445.
35. Anzenbacher P., Niwa T., Tolbert L.M., Sirimanne S.R., Guengerich F.P. Oxidation of 9-alkylanthracenes by cytochrome P450 2B1, horseradish peroxidase and iron tetraphenylporphine iodosylbenzene systems: anaerobic and aerobic mechanisms. Biochemistry. 35:1996;2512-2520.
36. Shou M., Yang S.K. 1-Hydroxy- and 2-hydroxy-3-methylcholanthrene: regioselective and stereoselective formations in the metabolism of 3-methylcholanthrene and enantioselective disposition in rat liver microsomes. Carcinogenesis. 11:1990;933-940.
37. Jeong H.K., Shlyankevich M., Surh Y.J. Intrinsic mutagenicity and electrophilicity of 1-sulfooxy-3-methylcholanthrene: implications for metabolic activation of the carcinogen 3-methylcholanthrene. Biochem. Mol. Biol. Int. 37:1995;885-893.
38. Glatt H.R., Pauly K., Frank H., Seidel A., Harvey R.G., Werle-Schneider G. Substance-dependent sex differences in the activation of benzylic alcohols to mutagens by hepatic sulfotransferases in the rat. Carcinogenesis. 15:1994;2605-2611.
39. Heflich R.H., Neft R.E. Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites. Mutat. Res. 318:1994;73-174.
40. Thakker D.R., Yagi H., Levin W., Wood A.W., Conney A.H., Jerina D.M. Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. Anders M.W. Bioactivation of Foreign Compounds. 1985;177-242 Academic Press, New York.
41. Rogan E.G., Cavalieri E.L., Walker B.A., Balasubramanian R., Wislocki P.G., Roth R.W., Saugier R.K. Mutagenicity of benzylic acetates, sulfates and bromides of polycyclic aromatic hydrocarbons. Chem.-Biol. Interact. 58:1986;253-275.
42. Rice J.E., Rivenson A., Braley J., LaVoie E.J. Methylated derivatives of pyrene and fluorene: evaluation of genotoxicity in the hepatocyte/DNA repair test and tumorigenic activity in newborn mice. J. Toxicol. Environ. Health. 21:1987;525-532.
43. Slaga T.J., Bracken W.M., Viaje A., Berry D.L., Fischer S.M., Miller D.R., Levin W., Conney A.H., Yagi H., Jerina D.M. Tumor-initiating and promoting activities of various benzo[a]pyrene metabolites in mouse skin. Jones P.W., Freudenthal R.I. Carcinogenesis. Polycnuclear Aromatic Hydrocarbons. 3:1978;371-382 Raven Press, New York.
44. Kapitulnik J., Wislock P.G., Levin W., Yagi H., Jerina D.M., Conney A.H. Tumorigenicity studies with diol-epoxides of benzo[a]pyrene which indicate that (±)-trans-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene is an ultimate carcinogen in newborn mice. Cancer Res. 38:1978;354-358.
45. Surh Y.-J., Kwon H.J., Tannenbaum S.R. Sulfotransferase-mediated activation of 4-hydroxy- and 3,4-dihydroxy-3,4-dihydrocyclopenta[c,d]pyrene, major metabolites of cyclopenta[c,d]pyrene. Cancer Res. 53:1993;1017-1022.
46. Evans F.E., Miller D.W., Beland F.A. Sensitivity of the conformation of deoxyguanosine to binding at the C-8 position by N-acetylated and unacetylated 2-aminofluorene. Carcinogenesis. 1:1980;955-959.
47. Heflich R.H., Neft R.E. Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites. Mutat. Res. 318:1994;73-174.
48. Mulder G.J., Hinson J.A., Nelson W.L., Thorgeirsson S.N. Role of sulfotransferase from rat liver in the mutagenicity of N-hydroxy-2-acetylaminofluorene in Salmonella typhimurium. Biochem. Pharmacol. 26:1977;1356-1357.
49. Glatt H.R., Oesch F., Neumann H.-G. Factors responsible for the metabolic formation and inactivation of bacterial mutagens from trans-4-acetylaminostilbene. Mutat. Res. 73:1980;237-250.
50. Monnerjahn S., Seidel A., Steinberg P., Oesch F., Hinz M., Stezowsky J.J., Hewer A., Phillips D.H., Glatt H.R. Formation of DNA adducts from 1-hydroxymethylpyrene in liver cells in vivo and in vitro. Phillips D.H., Castegnaro M., Bartsch H. Postlabelling Methods for Detection of DNA Adducts. 1993;189-193 IARC, Lyon.
51. Comer K.A., Falany C.N. Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal. Mol. Pharmacol. 41:1992;645-651.
52. Barker E.V., Hume R., Hallas A., Coughtrie M.W.H. Dehydroepiandrosterone sulfotransferase in the developing human fetus: quantitative biochemical and immunological characterization of the hepatic, renal and adrenal enzymes. Endocrinology. 134:1994;982-989.
53. Sundaram R.S., Szumlanski C., Otterness D., Van Loon J.A., Weinshilboum R.D. Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form. Drug Metab. Dispos. 17:1989;255-264.
54. Romiti P., Giuliani L., Pacifici G.M. Interindividual variability in the N-sulphation of desipramine in human liver and platelets. Br. J. Clin. Pharmacol. 33:1992;17-23.
55. Pacifici G.M., Eligi M., Giuliani L. (+) and (-) terbutaline are sulphated at a higher rate in human intestine than in liver. Eur. J. Clin. Pharmacol. 45:1993;483-487.
56. Hwang S.R., Kohn A.B., Hook V.Y.H. Molecular cloning of an isoform of phenol sulfotransferase from human brain hippocampus. Biochem. Biophys. Res. Commun. 207:1995;701-707.
57. Glatt H.R. Bioactivation of mutagens via sulfation. FASEB J. 11:1997;314-321.